Jul 25, 2019 | All Posts, Main Blog |
We always overestimate the change that will occur in the next two years and underestimate the change that will occur in the next 10.- Bill GatesGrowth opportunities are hard to come by without significant investment, but one major opportunity is a self-running engine...
Jul 16, 2019 | All Posts, BioPharma Marketing, Main Blog, Medical Device |
With special thanks to Hans Kaspersetz from Arteric who kindly shares this blog post. Hans will be presenting and chairing at our forthcoming (and currently in production) 2020 BioPharma eMarketing Summit on December 1-3 2020 in San Diego, CA. We’re aggressively...
Jul 11, 2019 | All Posts, BioPharma Marketing, Main Blog |
With special thanks to our sponsor EngagedMedia (a division of Aptus Health) who kindly share this case study in conjunction with the 2020 BioPharma eMarketing Summit May 5-7 2020in San Diego. (The only TED-style digital marketing event for BioPharma)There’s no doubt...
Jul 8, 2019 | Main Blog, Peptide |
There are a number of pharmacological and economical benefits to developing controlled and modified release drug products. Following the 505(b)(2) pathway allows companies to make modest changes to an already approved drug and get continued market exclusivity for a...
Jul 7, 2019 | Customized Event Advice, Main Blog |
A number of years ago, I was chatting with a friend of mine who works in market research and he turned to me and asked, “This may be a stupid question, but why do people attend conferences?” It made me pause to think for a moment. As a conference organizer, this is...
Jul 3, 2019 | Controlled Release, Main Blog, Peptide |
Big Picture Outlook According to markets & Markets, the drug delivery technology market is expected to reach USD $1,669.4 Billion by 2020 from USD $1,179.2 Billion in 2016, growing at a CAGR of 7.2% during the forecast period. Geographically, Asia is projected to...
Recent Comments